The effects of remifentanil anesthesia on glucose control in diabetic patients undergoing coronary artery bypass graft surgery
Not Applicable
Recruiting
- Conditions
- Diabetic patients undergoing coronary artery bypass graft surgery
- Registration Number
- JPRN-UMIN000016053
- Lead Sponsor
- Shiga university of medical science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Emergency surgeries hemodialysis patients The patient whom insulin, adrenalin, and steroid was used for in anesthesia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the levels of glucose in the blood the levels of adrenaline in the blood the levels of noradrenaline in the blood the levels of cortisol in the blood the levels of insuline in the blood
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does remifentanil anesthesia in JPRN-UMIN000016053 modulate glucose regulation pathways in diabetic CABG patients?
What is the comparative effectiveness of remifentanil versus propofol-based anesthesia on perioperative hyperglycemia in type 2 diabetic CABG patients?
Which biomarkers predict remifentanil-induced glucose stability in diabetic patients undergoing on-pump versus off-pump CABG?
What are the risks of hypoglycemic episodes with remifentanil use in diabetic CABG patients and optimal management strategies?
How do other opioid anesthetics like sufentanil or fentanyl compare to remifentanil in managing perioperative glucose homeostasis in diabetic cardiac surgery patients?